| Date Filed | Type | Description |
| 07/07/2023 |
4
| Malik Rajesh (Chief Medical Officer) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 1,361 shares
@ $2.4537, valued at
$3.3k
|
|
| 06/05/2023 |
4
| Malik Rajesh (Director) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 44,749 options to buy
@ $9.12, valued at
$408.1k
|
|
| 05/12/2023 |
4
| Malik Rajesh (Chief Medical Officer) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 35,000 shares
@ $0 |
|
| 01/05/2023 |
4
| Malik Rajesh (Chief Medical Officer) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 17,900 shares
@ $0
Sold 1,639 shares
@ $5.5756, valued at
$9.1k
Sold 729 shares
@ $5.4075, valued at
$3.9k
Granted 35,700 options to buy
@ $5.73, valued at
$204.6k
|
|
| 12/16/2022 |
4
| Malik Rajesh (Chief Medical Officer) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Exercised 14,000 options to buy
@ $0.3, valued at
$4.2k
|
|
| 11/28/2022 |
4
| Malik Rajesh (Director) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Bought 3,700 shares
@ $6.66, valued at
$24.6k
|
|
| 09/16/2022 |
4
| Malik Rajesh (Chief Medical Officer) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 18,000 shares
@ $15.7081, valued at
$282.7k
Exercised 18,000 options to buy
@ $0.39, valued at
$7k
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Malik Rajesh (Chief Medical Officer) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 12,000 shares
@ $0
Sold 1,445 shares
@ $10.6115, valued at
$15.3k
Granted 53,000 options to buy
@ $10.69, valued at
$566.6k
|
|
| 07/08/2021 |
4
| Malik Rajesh (Director) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 25,000 options to buy
@ $8.47, valued at
$211.8k
|
|
| 06/30/2021 |
3
| Malik Rajesh (Director) has filed a Form 3 on POINT Biopharma Global Inc. |
| 05/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| Malik Rajesh (Chief Medical Officer) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Exercised 3,100 options to buy
@ $0.39, valued at
$1.2k
|
|
| 01/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/11/2020 |
4
| Malik Rajesh (Ch. Medical Officer & SVP R&D) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 9,000 shares
@ $20.0611, valued at
$180.5k
Exercised 9,000 options to buy
@ $4.17, valued at
$37.5k
|
|
| 03/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4
| Malik Rajesh (Ch. Medical Officer & SVP R&D) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 60,000 options to buy
@ $21.08, valued at
$1.3M
|
|
| 01/24/2020 |
4
| Malik Rajesh (Ch. Medical Officer & SVP R&D) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Exercised 5,000 options to buy
@ $0.39, valued at
$2k
|
|
| 01/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2019 |
4
| Malik Rajesh (Ch. Medical Officer & SVP R&D) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 60,000 options to buy
@ $19.56, valued at
$1.2M
|
|
| 12/17/2018 |
4
| Malik Rajesh (Ch. Medical Officer & SVP R&D) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 3,776 shares
@ $30, valued at
$113.3k
Exercised 3,776 options to buy
@ $4.17, valued at
$15.7k
|
|
| 11/16/2018 |
4
| Malik Rajesh (Ch. Medical Officer & SVP R&D) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 3,529 shares
@ $39.713, valued at
$140.1k
Sold 247 shares
@ $40.314, valued at
$10k
Exercised 3,776 options to buy
@ $4.17, valued at
$15.7k
|
|
| 10/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2018 |
4
| Malik Rajesh (Ch. Medical Officer & SVP R&D) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 2,992 shares
@ $65.7753, valued at
$196.8k
Sold 484 shares
@ $66.7707, valued at
$32.3k
Sold 300 shares
@ $67.95, valued at
$20.4k
Exercised 3,776 options to buy
@ $4.17, valued at
$15.7k
|
|
| 08/17/2018 |
4
| Malik Rajesh (Ch. Medical Officer & SVP R&D) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 2,076 shares
@ $55.3823, valued at
$115k
Sold 1,700 shares
@ $56.4994, valued at
$96k
Exercised 3,776 options to buy
@ $4.17, valued at
$15.7k
|
|
| 07/17/2018 |
4
| Malik Rajesh (Ch. Medical Officer & SVP R&D) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 2,514 shares
@ $41.909, valued at
$105.4k
Sold 1,262 shares
@ $42.7008, valued at
$53.9k
Exercised 3,776 options to buy
@ $4.17, valued at
$15.7k
|
|
| 06/18/2018 |
4
| Malik Rajesh (Ch. Medical Officer & SVP R&D) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 3,776 shares
@ $44.3131, valued at
$167.3k
Exercised 3,776 options to buy
@ $4.17, valued at
$15.7k
|
|
| 06/11/2018 |
4
| Malik Rajesh (Ch. Medical Officer & SVP R&D) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Exercised 4,200 options to buy
@ $0.39, valued at
$1.6k
|
|
|